Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
03/2012
03/29/2012US20120076762 Induced pluripotent stem cell generation using two factors and p53 inactivation
03/29/2012US20120073508 Insulin-like gene in prawns and uses thereof
03/29/2012CA2812363A1 Substituted polycyclic carbamoyl pyridone derivative prodrug
03/29/2012CA2810706A1 Substituted amide compound
03/28/2012EP2434282A2 Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers
03/28/2012EP2434010A1 Prophylactic and/or therapeutic agent for metabolic syndrome
03/28/2012EP2433940A1 Spiroimidazolone derivative
03/28/2012EP2433938A1 Therapeutic agent for motor disorders
03/28/2012EP2433932A1 Prophylactic And/Or Therapeutic Agent For Hyperlipidemia
03/28/2012EP2433625A1 Anti-obesity agent comprising compound containing benzotropolone ring
03/28/2012EP2433623A1 Use of dipeptidylpeptidase inhibitors to regulate glucose metabolism
03/28/2012EP2432471A1 Novel therapeutic concepts for treating fibromyalgia
03/28/2012EP2095825B8 Method for treating human diseases associated with an increased deoxyribonucleic acid content in extracellular spaces of tissues and a medicinal preparation for carrying out said method
03/28/2012EP1579872B1 Body weight gain inhibitor
03/28/2012EP1543830B1 Antiseptic bactericides and cosmetics, drugs and foods containing the antiseptic bactericides
03/28/2012EP1527047B1 3-z- 1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl)-n-me thyl-amino)-anilino)-1-phenyl-methylene -6-methoxycarbonyl-2 -indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composition
03/28/2012EP1453508B1 Tempamine compositions and use against cellular oxidative damage
03/28/2012EP1117689B1 Bone morphogenetic protein antagonists based on the mature protein
03/28/2012CN1635901B Remodeling and glycoconjugation of peptides
03/28/2012CN102395603A Diagnosis and treatment of cancer using anti-lgr7 antibody
03/28/2012CN102395589A Fused pyrrolopyridine derivative
03/28/2012CN102395577A Diazepinedione derivative
03/28/2012CN102395571A Novel triazine derivative and pharmaceutical composition containing same
03/28/2012CN102395364A Pharmaceutical compositions
03/28/2012CN101188949B Egg-derived bone-strengthening composition
03/27/2012US8143421 Broadspectrum substituted benzimidazole sulfonamide HIV protease inhibitors
03/27/2012US8143005 Nucleic acids encoding sodium channel SCN1A alpha subunit proteins and mutations associated with epilepsy
03/27/2012US8142778 Methods of treatment using CTLA-4 antibodies
03/27/2012US8142773 Isolating progenitor cell tissue via antibody specific binding, transfering into recipient host, monitor cell propagation; tissue engineering; regenerative medicine
03/27/2012US8142772 Attack of tumor cells with missing, low or aberrant MHC expression by combining non MHC-restricted T-cells/NK-cells and MHC-restricted cells
03/27/2012CA2667068C 2-pyridinecarboxamide derivative having gk-activating effect
03/27/2012CA2489862C Epimerized derivatives of k5 polysaccharide with a very high degree of sulfation
03/27/2012CA2473669C Use and preparation of dosage forms containing benzimidazole derivatives and a buffer
03/27/2012CA2470245C Ifnar2 mutants, their production and use
03/27/2012CA2447091C Methods for the treatment and prevention of pain using stress-activated protein kinase
03/27/2012CA2435812C Process and compositions for peptide, protein and peptidomimetic synthesis
03/27/2012CA2407423C Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
03/27/2012CA2406179C Use of defibrotide and at least one haematopoietic factor to mobilize haematopoietic progenitors
03/27/2012CA2400244C Antiadhesive carbohydrates comprising a terminal uronic acid unit containing a carbon-carbon double bond
03/27/2012CA2389570C Methods for treating mild cognitive impairment
03/27/2012CA2362964C Fucosyl transferase gene
03/27/2012CA2309903C Nucleic acid sequences encoding capsaicin receptor
03/27/2012CA2245496C Receptor protein designated 2f1
03/22/2012WO2012037562A2 Pharmaceutical and nutraceutical compositions of abscisic acid
03/22/2012WO2012036287A1 Novel cortistatin a analog and use thereof
03/22/2012WO2012036276A1 Glycine transporter inhibitory substance
03/22/2012WO2012036268A1 Glycine transporter inhibitory substance
03/22/2012WO2012036233A1 Condensed heterocyclic derivative having melanine-concentrating hormone receptor antagonistic activity
03/22/2012WO2012036193A1 Therapeutic agent for fatty liver disease containing p2x7 receptor inhibitory substance as active ingredient
03/22/2012WO2012035904A1 Agent for promoting hyaluronic acid production
03/22/2012WO2012035770A1 Osteogenesis promoting agent containing glycogen
03/22/2012WO2012035747A1 Cancer heat therapy-enhancing agent
03/22/2012WO2012035685A1 Composition for promoting hyaluronic acid production
03/22/2012WO2012035557A1 Novel cationic amphiphiles with mannose-mimicking head-groups and a process for the preparation thereof
03/22/2012WO2012034534A1 Use of the traditional chinese medicine composition for manufacturing a health food or medicament for preventing and alleviating physical fatigue
03/22/2012WO2012034194A1 Method for mobilizing stem and/or progenitor cells
03/22/2012US20120071839 Tampon
03/22/2012US20120071657 Triazole compounds useful as protein kinase inhibitors
03/22/2012US20120071653 Human Adam-10 Inhibitors
03/22/2012US20120071556 Pharmaceutical and nutraceutical compositions of abscisic acid
03/22/2012US20120071555 Compositions of abscisic acid for animal health
03/22/2012US20120071539 Compounds and methods for modulating the silencing of a polynucleotide of interest
03/22/2012US20120071537 New Oral Formulation
03/22/2012US20120071506 Methods for treating cns disorders with bicyclo-substituted 2-imidazoline and 2-imidazoles
03/22/2012US20120071486 Thienopyrimidine compounds and use thereof
03/22/2012US20120071477 Cdki pathway inhibitors and uses thereof
03/22/2012US20120070501 Method and Formulation for Treating Resistance to Antihypertensives and Related Conditions
03/22/2012US20120070494 Treatment for Attention-Deficit Hyperactivity Disorder
03/22/2012US20120070473 Apparatus and Method for Reducing the Occurrence of Post-Surgical Adhesions
03/22/2012US20120070460 Dendritic cell modulatory molecule
03/22/2012US20120070441 Extracellular yaluronidase from streptomyces koganeiensis
03/22/2012US20120070369 Hif inhibitors and use thereof
03/22/2012CA2811228A1 Method for mobilizing stem and/or progenitor cells
03/21/2012EP2431480A2 Methods and compositions for increasing the stress resistance of cells and organisms
03/21/2012EP2431377A1 Modified L-nucleic acids
03/21/2012EP2431365A1 Azetidine compound and medicinal use thereof
03/21/2012EP2431037A1 (2S,3R)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, novel salt forms, and methods of use thereof
03/21/2012EP2431028A2 Fast-dissolving oral film for effectively concealing unpleasant tastes
03/21/2012EP2430923A1 Compositions and methods for liver growth and liver protection
03/21/2012EP2429559A1 Treatment of pain and/or inflammation and treatment and prevention of a skin or mucosal disease and/or condition
03/21/2012EP2188254B1 Novel bradykinin b1-antagonists
03/21/2012EP2133335B9 Sphingosine compound, method for producing the same, and sphingomyelinase inhibitor
03/21/2012EP2123636B1 Method for producing aminoacetylpyrrolidinecarbonitrile derivative
03/21/2012EP2018869B1 Licorice polyphenol preparation
03/21/2012EP1683788B1 Derivatives of pyridone and use thereof
03/21/2012EP1506409B1 Assays for modulators of asparaginyl hydroxylase
03/21/2012EP1488808B1 Remedies for glomerular diseases
03/21/2012EP1478399B1 Oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient
03/21/2012EP1439174B1 4-IMIDAZOLIN-2-ONE COMPOUNDS AS p38 MAP KINASE INHIBITORS
03/21/2012EP1422218B1 Antiviral agent
03/21/2012EP1404412B1 Protein C for wound healing
03/21/2012EP1387854B1 Sfrp and peptide motifs that interact with sfrp and methods of their use
03/21/2012EP1320540B9 Peptidomimetic protease inhibitors
03/21/2012EP1313853B1 Modulation of fas and fasl expression by a synthetic phosphodiester oligonucleotide and an anti-fas antibody
03/21/2012EP1248779B1 Glycosidase ihhibitors and preparation thereof
03/21/2012EP0692972B2 Method for delivering beneficial compositions to hair follicles
03/21/2012CN102388031A Inhibitor for elevation of gip level
03/21/2012CN102387808A Immunopotentiating composition and process for producing same
03/21/2012CN102387803A Use of tetrahydrobiopterin as a marker and a therapeutic agent for fabry disease
03/21/2012CN102380030A TCM composition applied to preparation of medication for treating siriasis
1 ... 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 ... 1564